Word: folkman
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...funds raised will go to higher-risk projects with potentially greater paybacks. It's a science version of throwing it long. "If you run the same play every time, you're not going to win the game," says Armstrong. One of SU2C's advisers was the late Judah Folkman, a famed cancer scientist whose pathbreaking theory that tumors grow via angiogenesis (creating their own blood supply) was resisted for decades. "There may be other Judah Folkmans out there," says Ziskin. "We don't want them wandering around for 40 years...
...when his findings were published in the New England Journal of Medicine, cancer researcher Judah Folkman's peers dismissed his idea that cancer tumors were dependent on a growing network of blood vessels. The now widely accepted theory that blocking angiogenesis, or vessel growth, will inhibit tumors has led to a dedicated field of research and at least 10 drugs currently on the market. Folkman was 74 and died of an apparent heart attack...
...Judah Folkman, a Harvard Medical School professor and a groundbreaking biomedical pioneer, died of a heart attack in the Denver International Airport on Monday. He was 74. Folkman was most famous for his impact on cancer treatment through his investigation of blood vessels’ role in tumor growth. A tireless innovator and mentor, he is also remembered for personally and professionally inspiring patients, students, and peers. “The field of cancer research has lost one of its most passionate, committed and creative warriors,” Edward Benz Jr., president of the Harvard-affiliated Dana-Farber Institute...
...road wasn't always easy, however. Folkman's first compound, which biotech companies rushed to test in people at the beginning of this decade, proved less effective in patients than in mice, giving skeptics yet another reason to doubt the approach. But that agent, dismissed by U.S. researchers, eventually won approval in 2005 for treating lung cancer in China, where it is extending the lives of non-small-cell lung cancer patients...
...amazing mind," says Brem. Even before his pioneering work in cancer treatments, Folkman and a colleague, while in the Navy, perfected what they called a "leaky plastic," which later became the basis for the implantable, time-release contraceptive Norplant. Not only did Folkman's work on angiogenesis benefit cancer patients, but the same principles are now leading to novel treatments for reviving dying heart tissue, restoring circulation to tissues crippled by diabetes and improving vision in patients with macular degeneration. His theories may yet impact the treatment of other conditions, including obesity: "More recently, he had the idea that...